Lab News
Gestalt plans AI tool for triaging pathology cases
April 25, 2019 -- Gestalt Diagnostics is developing a new artificial intelligence (AI) algorithm that it believes will improve digital pathology workflow by triaging cases to the appropriate professional. It plans to integrate the tool into its PathFlow enterprise software platform later this year.
What impact does genetic testing have on breast cancer treatment?
April 24, 2019 -- Genetic testing of all women newly diagnosed with a common type of breast cancer could save money in the short term by cutting down on the use of chemotherapy; however, the long-term outlook is unclear, according to a study published April 24 in the Journal of the National Cancer Institute.  Discuss
Prescient Medicine buys AutoGenomics for Infiniti test
April 24, 2019 -- Prescient Medicine Holdings announced it has acquired AutoGenomics, a molecular diagnostics company that developed the Infiniti microarray-based multiplexing diagnostic system.
RxGenomix, Coriell ink partnership
April 24, 2019 -- RxGenomix and Coriell Life Sciences have signed a partnership intended to make it easier for healthcare providers to offer pharmacogenomic services.
Epic Sciences gets CE Mark for liquid biopsy kit
April 24, 2019 -- Epic Sciences has received the CE Mark for its liquid biopsy test collection kit.
Liquid biopsy results help TARGET cancer treatments in U.K. study
April 23, 2019 -- Circulating tumor DNA tests are practical for genomic profiling of tumors and guiding cancer patients to early-stage clinical trials of targeted therapies accordingly, a U.K. study published April 22 in Nature Medicine has found.  Discuss
Researchers link protein group to end-stage renal disease
April 23, 2019 -- The presence of a group of inflammatory proteins could signify that patients with diabetic kidney disease may be at risk of progressing to end-stage renal disease, according to a study published April 22 in Nature Medicine.  Discuss
Biocartis signs deal with Covance for Idylla molecular testing
April 23, 2019 -- Belgian molecular diagnostics developer Biocartis Group has signed a deal to make its Idylla molecular testing technology available to customers of Covance for use in drug development.
Blood test data show Lyme disease rising in some states
April 22, 2019 -- The demographics of tick-borne Lyme disease in the U.S. have been changing, with more testing and diagnoses in states that traditionally have had a low incidence of the infection, according to a study of blood-based testing by researchers from Massachusetts General Hospital and Quest Diagnostics.  Discuss
Pathology AI developer PathAI raises $60M
April 22, 2019 -- Pathology artificial intelligence (AI) software developer PathAI has raised $60 million in a series B funding round.
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets